NOD1 and metabolic disease: Two studies, one comparing subcutaneous adipose tissue obtained from 18 women with gestational diabetes to those from 28 healthy pregnant patients [6] and the other examining subcutaneous adipose tissue taken from 34 subjects with metabolic syndrome [9], showed an increase of NOD1, but not NOD2 expression in individuals with metabolic disease.